Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bempedoic Acid Therapy for Polycystic Kidney Disease (BEAT-PKD) Randomized Clinical Trial

NCT07282821 is registered in ClinicalTrials.gov with Kenneth Hallows as lead sponsor.

NCT NCT07282821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07282821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bempedoic Acid Therapy for Polycystic Kidney Disease (BEAT-PKD) Randomized Clinical Trial
Lead sponsor
Kenneth Hallows
Phase
Phase 2
Overall status
Recruiting
Start date
September 30, 2026
Completion date
March 31, 2030
Enrollment
120 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

adpkd (autosomal dominant polycystic kidney disease)